《平价医疗法案》市场及医疗补助资格扩大对癌症护理可及性的影响
Effects of Affordable Care Act Marketplaces and Medicaid Eligibility Expansion on Access to Cancer Care.
作者信息
Graves John A, Swartz Katherine
机构信息
From the *Departments of Health Policy and Medicine, Vanderbilt University School of Medicine, Nashville, TN; and †Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Harvard University, Boston, MA.
出版信息
Cancer J. 2017 May/Jun;23(3):168-174. doi: 10.1097/PPO.0000000000000260.
PURPOSE
The aim of this study was to inform oncologists about how repealing the Affordable Care Act (ACA) may affect their ability to provide cancer therapies for people with cancer enrolled in ACA health plans and why proposals to change Medicaid funding may make it even more difficult for Medicaid beneficiaries to access cancer treatments.
METHODS
We examined the regulations and provisions of the ACA related to how health insurance impacts access to diagnostic testing and treatments for people with cancer, including access to clinical trials. Similarly, we examined federal and state rules affecting Medicaid beneficiaries' access to cancer treatments.
RESULTS
Repealing various provisions of the ACA will restrict who has access to both current and new cancer treatments. Such changes also will impact oncology research that depends on having heterogeneous people in clinical trials.
CONCLUSIONS
Significant changes to the ACA will affect oncology treatment choices of everyone with health insurance-not only the 10 million people newly covered by ACA health plans and the 70 million people with Medicaid coverage.
目的
本研究旨在告知肿瘤学家，废除《平价医疗法案》（ACA）可能如何影响他们为参加ACA医保计划的癌症患者提供癌症治疗的能力，以及为何改变医疗补助资金的提议可能会使医疗补助受益人更难获得癌症治疗。
方法
我们研究了ACA中与医疗保险如何影响癌症患者获得诊断检测和治疗（包括参加临床试验）相关的法规和条款。同样，我们研究了影响医疗补助受益人获得癌症治疗的联邦和州规则。
结果
废除ACA的各项条款将限制能够获得现有和新癌症治疗的人群。此类变化还将影响依赖于临床试验中有不同人群参与的肿瘤学研究。
结论
ACA的重大变化将影响每个有医疗保险的人的肿瘤治疗选择——不仅是新参加ACA医保计划的1000万人和有医疗补助覆盖的7000万人。
Zotero 插件